Reversal of hepatitis B virus‐induced immune tolerance by an immunostimulatory 3p‐HBx‐siRNAs in a retinoic acid inducible gene I–dependent manner

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Hepatology

• Publication date

  2011-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/hep.24505PMID 21721030
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• RIG-I detects viral genomic RNA during negative-strand RNA virus infection.

  2010influential reference
• Hepatitis B virus X protein suppresses virus-triggered IRF3 activation and IFN-β induction by disrupting the VISA-associated complex

  2010cited by this paper
• Hepatitis B Virus Regulatory HBx Protein Binds to Adaptor Protein IPS-1 and Inhibits the Activation of Beta Interferon

  2010cited by this paper
• The Hepatitis B Virus X Protein Disrupts Innate Immunity by Downregulating Mitochondrial Antiviral Signaling Protein

  2010cited by this paper
• Hepatitis B virus polymerase inhibits RIG-I- and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKKepsilon and DDX3.

  2010cited by this paper
• Astrocytes are very sensitive to develop innate immune responses to lipid‐carried short interfering RNA

  2009cited by this paper
• Recognition of 5' triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus.

  2009cited by this paper
• Patients with chronic hepatitis B infection display deficiency of plasmacytoid dendritic cells with reduced expression of TLR9.

  2009cited by this paper
• Cytosolic Viral Sensor RIG-I Is a 5'-Triphosphate–Dependent Translocase on Double-Stranded RNA

  2009cited by this paper
• Host immunity influences disease progression and antiviral efficacy in humans infected with hepatitis B virus

  2009cited by this paper
• Hepatitis B virus suppresses toll‐like receptor–mediated innate immune responses in murine parenchymal and nonparenchymal liver cells

  2009influential reference
• Immunostimulatory RNA Blocks Suppression by Regulatory T Cells

  2009cited by this paper
• Activation of Pattern Recognition Receptor-Mediated Innate Immunity Inhibits the Replication of Hepatitis B Virus in Human Hepatocyte-Derived Cells

  2008cited by this paper
• Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid–inducible gene-I and melanoma differentiation–associated gene 5

  2008cited by this paper
• New concepts in the immunopathogenesis of chronic hepatitis B: the importance of the innate immune response

  2008cited by this paper
• 5′-triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma

  2008cited by this paper
• Processing of Genome 5′ Termini as a Strategy of Negative-Strand RNA Viruses to Avoid RIG-I-Dependent Interferon Induction

  2008cited by this paper
• Nonself RNA-sensing mechanism of RIG-I helicase and activation of antiviral immune responses.

  2008influential reference
• Design of bifunctional siRNAs: combining immunostimulation and gene-silencing in one single siRNA molecule.

  2007cited by this paper
• Toll‐like receptor‐mediated control of HBV replication by nonparenchymal liver cells in mice

  2007cited by this paper
• 5'-Triphosphate RNA Is the Ligand for RIG-I

  2006cited by this paper
• RIG-I-Mediated Antiviral Responses to Single-Stranded RNA Bearing 5'-Phosphates

  2006cited by this paper
• Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase

  2004cited by this paper
• Inhibition of Cellular Proteasome Activities Enhances Hepadnavirus Replication in an HBX-Dependent Manner

  2004cited by this paper
• Activation of the interferon system by short-interfering RNAs

  2003cited by this paper
• Hepatitis B virus downregulates the human interferon-inducible MxA promoter through direct interaction of precore/core proteins.

  2003cited by this paper
• Hepatic T cells and liver tolerance

  2003cited by this paper
• Inhibition of hepatitis B virus expression and replication by RNA interference

  2003cited by this paper

• HBx protein as a therapeutic target for functional cure of hepatitis B virus infection.

  2025cites this paper
• Combining RNA Interference and RIG-I Activation to Inhibit Hepatitis E Virus Replication

  2024cites this paper
• Identification of a potent and specific retinoic acid-inducible gene 1 pathway activator as a Hepatitis B Virus antiviral through a novel cell-based reporter assay.

  2024cites this paper
• Antiviral activity of HuaganJiedu Decoction (HGJDD) against hepatitis B virus (HBV) through FOXO4/ERK/HNF4α signal pathway.

  2024cites this paper
• LDHB Mediates Histone Lactylation to Activate PD-L1 and Promote Ovarian Cancer Immune Escape

  2024cites this paper
• Innate immune regulations and various siRNA modalities

  2023cites this paper
• The emerging role of DEAD/H-box helicases in hepatitis B virus infection

  2022cites this paper
• Enhancing anti-tumor efficacy and immune memory by combining 3p-GPC-3 siRNA treatment with PD-1 blockade in hepatocellular carcinoma

  2022cites this paper
• Regulation of Pattern-Recognition Receptor Signaling by HBX During Hepatitis B Virus Infection

  2022cites this paper
• PreS/2-21-Guided siRNA Nanoparticles Target to Inhibit Hepatitis B Virus Infection and Replication

  2022cites this paper
• Codelivery of HBx-siRNA and Plasmid Encoding IL-12 for Inhibition of Hepatitis B Virus and Reactivation of Antiviral Immunity

  2022cites this paper
• Combination of natural killer cell-based immunotherapy and irreversible electroporation for the treatment of hepatocellular carcinoma

  2021cites this paper
• A Putative Amphipathic Alpha Helix in Hepatitis B Virus Small Envelope Protein Plays a Critical Role in the Morphogenesis of Subviral Particles

  2021cites this paper
• Immunopathogenesis of HBV Infection.

  2020cites this paper
• Antiviral activity of a polysaccharide from Radix Isatidis (Isatis indigotica Fortune) against hepatitis B virus (HBV) in vitro via activation of JAK/STAT signal pathway.

  2020cites this paper
• Hepatitis B Virus Infection: Molecular Virology to Antiviral Drugs

  2020cites this paper
• Hepatitis B virus X protein promotes tumor invasion and poor prognosis in hepatocellular carcinoma via phosphorylation of paxillin at Serine 178 by activation of the c-Jun NH2-terminal kinase.

  2020cites this paper
• 5′‐triphosphate siRNA targeting HBx elicits a potent anti‐HBV immune response in pAAV‐HBV transfected mice

  2019cites this paper
• Hepatitis B Virus Infection: Overview.

  2019cites this paper
• MiR-3613-3p impairs IFN-induced immune response by targeting CMPK1 in chronic hepatitis B.

  2019cites this paper
• GADD45α alleviates acetaminophen-induced hepatotoxicity by promoting AMPK activation

  2018cites this paper
• Combinational immune-cell therapy of natural killer cells and sorafenib for advanced hepatocellular carcinoma: a review

  2018cites this paper
• RNA Interference-Induced Innate Immunity, Off-Target Effect, or Immune Adjuvant?

  2017cites this paper
• RNA interference-based technology: what role in animal agriculture?

  2017cites this paper
• Hepatitis B virus inhibits intrinsic RIG-I and RIG-G immune signaling via inducing miR146a

  2016cites this paper
• Perspectives on RNA Interference in Immunopharmacology and Immunotherapy

  2016cites this paper
• siRNA and RNAi optimization

  2016cites this paper
• Interplay between hepatitis B virus and innate immune signaling pathways

  2015cites this paper
• Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy

  2015cites this paper
• Bifunctional siRNA containing immunostimulatory motif enhances protection against pandemic H1N1 virus infection.

  2015cites this paper
• TLR7/8 agonists promote NK-DC cross-talk to enhance NK cell anti-tumor effects in hepatocellular carcinoma.

  2015cites this paper
• Modeling hepatitis B virus infection, immunopathology and therapy in mice.

  2015cites this paper
• Harnessing RNAi to Silence Viral Gene Expression

  2015cites this paper
• Gene Therapy for Chronic Hepatitis B Virus Infection

  2015cites this paper
• New insights into hepatitis B virus biology and implications for novel antiviral strategies

  2015cites this paper
• RIG-I in RNA virus recognition

  2015cites this paper
• The Liver and Immune Tolerance

  2014cites this paper
• Interplay between hepatitis B virus and the innate immune responses: implications for new therapeutic strategies

  2014cites this paper
• Intracellular Poly(I:C) Initiated Gastric Adenocarcinoma Cell Apoptosis and Subsequently Ameliorated NK Cell Functions

  2014cites this paper
• Hepatitis B Virus Polymerase Disrupts K63-Linked Ubiquitination of STING To Block Innate Cytosolic DNA-Sensing Pathways

  2014cites this paper
• miR146a impairs the IFN‐induced anti‐HBV immune response by downregulating STAT1 in hepatocytes

  2014cites this paper
• Phosphorothioate modification of the TLR9 ligand CpG ODN inhibits poly(I:C)-induced apoptosis of hepatocellular carcinoma by entry blockade.

  2014cites this paper
• Phosphorothioate-modified CpG oligodeoxynucleotide (CpG ODN) induces apoptosis of human hepatocellular carcinoma cells independent of TLR9

  2014cites this paper
• Chemical modifications on siRNAs avoid Toll-like-receptor-mediated activation of the hepatic immune system in vivo and in vitro.

  2014cites this paper
• Therapeutic strategies for a functional cure of chronic hepatitis B virus infection

  2014cites this paper
• Effect and mechanisms of curdlan sulfate on inhibiting HBV infection and acting as an HB vaccine adjuvant.

  2014cites this paper
• Suppression of Interferon‐Mediated Antiviral Immunity by Hepatitis B Virus: An Overview of Research Progress

  2013cites this paper
• The liver works as a school to educate regulatory immune cells

  2013cites this paper
• Antiviral activity of methyl helicterate isolated from Helicteres angustifolia (Sterculiaceae) against hepatitis B virus.

  2013cites this paper
• Hepatocystin/80K-H inhibits replication of hepatitis B virus through interaction with HBx protein in hepatoma cell.

  2013cites this paper
• Inhibition of hepatitis B virus (HBV) gene expression and replication by HBx gene silencing in a hydrodynamic injection mouse model with a new clone of HBV genotype B

  2013cites this paper
• Strategies for designing and validating immunostimulatory siRNAs.

  2013cites this paper
• Therapeutic recovery of hepatitis B virus (HBV)‐induced hepatocyte‐intrinsic immune defect reverses systemic adaptive immune tolerance

  2013cites this paper
• NK cells in immunotolerant organs

  2013cites this paper
• Reversal of hepatitis B virus‐induced systemic immune tolerance by intrinsic innate immune stimulation

  2013cites this paper
• Immunocompetent nontransgenic mouse models for studying hepatitis B virus immune responses

  2013cites this paper
• Isolation and identification of an anti-hepatitis B virus compound from Hydrocotyle sibthorpioides Lam.

  2013cites this paper
• 5'-triphosphate-siRNA activates RIG-I-dependent type I interferon production and enhances inhibition of hepatitis B virus replication in HepG2.2.15 cells.

  2013cites this paper
• 5′-Triphosphate-siRNA Against Survivin Gene Induces Interferon Production and Inhibits Proliferation of Lung Cancer Cells In Vitro

  2013cites this paper
• Antiviral Effects of Small Interfering RNA Simultaneously Inducing RNA Interference and Type 1 Interferon in Coxsackievirus Myocarditis

  2012cites this paper
• The innate immune response to hepatitis B virus infection: implications for pathogenesis and therapy.

  2012cites this paper
• IMMUNOREGULATION OF HEPATITIS B VIRUS INFECTION―RATIONALE AND CLINICAL APPLICATION―

  2012cites this paper
• The role of innate immunity in HBV infection

  2012cites this paper
• Living in the liver: hepatic infections

  2012cites this paper
• Involvement of Activation of PKR in HBx-siRNA-Mediated Innate Immune Effects on HBV Inhibition

  2011cites this paper